Optimizing Treatment De‐Escalation in Head and Neck Cancer: Current and Future Perspectives

מאת Rosenberg, Ari J., Vokes, Everett E.
הוצא לאור ב Oncologist (2020)

MET as a target for treatment of chest tumours

מאת Cipriani, Nicole A., Abidoye, Oyewale O., Vokes, Everett E., Salgia, Ravi
יצא לאור 2008

Randomized Phase II Trial of Docetaxel Plus Cetuximab or Docetaxel Plus Bortezomib in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2: CALGB 30402

מאת Lilenbaum, Rogerio, Wang, Xiaofei, Gu, Lin, Kirshner, Jeffrey, Lerro, Keith, Vokes, Everett
יצא לאור 2009

Cyclooxygenase-2 (COX-2) As a Predictive Marker for the Use of COX-2 Inhibitors in Advanced Non–Small-Cell Lung Cancer

מאת Edelman, Martin J., Hodgson, Lydia, Wang, Xiaofei, Kratzke, Robert A., Vokes, Everett E.
יצא לאור 2012

Crizotinib (PF02341066) as a ALK /MET inhibitor— Special Emphasis as a Therapeutic Drug Against Lung Cancer

מאת Nwizu, Tobenna, Kanteti, Rajani, Kawada, Ichiro, Rolle, Cleo, Vokes, Everett E., Salgia, Ravi
הוצא לאור ב Drugs Future (2011)

A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non...

מאת Masters, Gregory A., Wang, Xiaofei, Hodgson, Lydia, Shea, Thomas, Vokes, Everett, Green, Mark
הוצא לאור ב Lung Cancer (2011)

Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304

מאת Edelman, Martin J., Hodgson, Lydia, Wang, Xiaofei, Christenson, Robert, Jewell, Scott, Vokes, Everett, Kratzke, Robert
הוצא לאור ב J Thorac Oncol (2011)

Adjuvant treatment for high‐risk salivary gland malignancies and prognostic stratification based on a 20‐year single institution experience

מאת Onderdonk, Benjamin E., Vokes, Everett E., Gwede, Michael, Blair, Elizabeth, Agrawal, Nishant, Haraf, Daniel J.
הוצא לאור ב Health Sci Rep (2020)

Factors Associated with Clinical Benefit from Epidermal Growth Factor Receptor Inhibitors in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck

מאת Wyssam Cohen, Ezra Eddy, Halpern, Anna B., Kasza, Kristen, Kocherginsky, Masha, Williams, Rosalyn, Vokes, Everett E.
יצא לאור 2009

Evaluation of Oncology Trial Results Reporting Over a 10-Year Period

מאת Liu, Xu, Zhang, Yuan, Li, Wen-Fei, Vokes, Everett, Sun, Ying, Le, Quynh-Thu, Ma, Jun
הוצא לאור ב JAMA Netw Open (2021)

CYFRA 21-1 as a prognostic and predictive marker in advanced non-small cell lung cancer in a prospective trial: CALGB 150304

מאת Edelman, Martin J., Hodgson, Lydia, Rosenblatt, Paula Y., Christenson, Robert H., Vokes, Everett, Wang, Xiaofei, Kratzke, Robert
הוצא לאור ב J Thorac Oncol (2012)

Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

מאת Rudin, Charles M., Salgia, Ravi, Wang, Xiaofei, Hodgson, Lydia D., Masters, Gregory A., Green, Mark, Vokes, Everett E.
יצא לאור 2008

Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer

מאת Kawada, Ichiro, Hasina, Rifat, Arif, Qudsia, Mueller, Jeffrey, Smithberger, Erin, Husain, Aliya N., Vokes, Everett E., Salgia, Ravi
הוצא לאור ב Cancer Res (2013)

Heuristic value-based framework for lung cancer decision-making

מאת Mambetsariev, Isa, Pharaon, Rebecca, Nam, Arin, Knopf, Kevin, Djulbegovic, Benjamin, Villaflor, Victoria M., Vokes, Everett E., Salgia, Ravi
הוצא לאור ב Oncotarget (2018)

Efficacy of the Multi-Kinase Inhibitor Enzastaurin is Dependent on Cellular Signaling Context

מאת Kuo, Wen-Liang, Liu, Jing, Mauceri, Helena, Vokes, Everett E, Weichselbaum, Ralph, Rosner, Marsha Rich, Cohen, Ezra Eddy Wyssam
יצא לאור 2010

Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lung Cancer: Ca...

מאת Govindan, Ramaswamy, Bogart, Jeffrey, Stinchcombe, Thomas, Wang, Xiaofei, Hodgson, Lydia, Kratzke, Robert, Garst, Jennifer, Brotherton, Timothy, Vokes, Everett E.
יצא לאור 2011

Phase II study of dasatinib in patients with previously treated malignant mesothelioma (Cancer and Leukemia Group B 30601): a brief report

מאת Dudek, Arkadiusz Z., Pang, Herbert, Kratzke, Robert A., Otterson, Gregory A., Hodgson, Lydia, Vokes, Everett E., Kindler, Hedy L.
יצא לאור 2012

Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy

מאת Maggiore, Ronald J., Curran, Emily K., Witt, Mary Ellyn, Haraf, Daniel J., Vokes, Everett E., Cohen, Ezra E.W.
הוצא לאור ב J Geriatr Oncol (2013)

The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II Consortium

מאת Nimeiri, Halla S., Singh, Deepti A., Kasza, Kristen, Taber, David A., Ansari, Rafat H., Vokes, Everett E., Kindler, Hedy L.
הוצא לאור ב Invest New Drugs (2009)

Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B trial 9430

מאת Stinchcombe, Thomas E., Mauer, Ann M., Hodgson, Lydia D., Herndon, James E., Lynch, Thomas J., Green, Mark. R., Vokes, Everett E.
יצא לאור 2008